NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000673

Registered date:31/12/2008

Cilostazol in Acute Ischemic Stroke Trial

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedischemic stroke
Date of first enrollment2006/11/01
Target sample size350
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Patients will be randomly selected to receive cilostazol. Patients will also be randomly selected to receive treatment with conventional therapy.

Outcome(s)

Primary Outcomemodified Rankin scale 0-2 at 3 month
Secondary OutcomeRecurrence of stroke, NIHSS, JSS, Barthel Indes, modified Rankin Scale, Zung, MMSE, Neurological deterioration, Pneumonia

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1.cardiogenic embolism 2.previous ischemic stroke episode within 6 months 3.hemorrhagic stroke 4.consciousness disturbance 5.prestroke modified Rankin Scale 2<= 6.malignancy 7.pregnancy 8.allergic to cilostazol

Related Information

Contact

public contact
Name Haruhiko Hoshino
Address 35 Shinanomachi Shinjuku-ku Tokyo 165-8582 Japan Japan
Telephone 03-3353-1211
E-mail hhoshino-keio@umin.ac.jp
Affiliation Keio University School of Medicine Department of Neurology
scientific contact
Name Norihiro Suzuki
Address 35 Shinanomachi Shinjuku-ku Tokyo 165-8582 Japan Japan
Telephone 03-3353-1211
E-mail
Affiliation Keio University School of Medicine Department of Neurology